Literature DB >> 733423

Measles vaccine efficacy in children previously vaccinated at 12 months of age.

J S Marks, T J Halpin, W A Orenstein.   

Abstract

During a large outbreak of measles in Ohio in 1976 it was possible to measure measles vaccine efficacy by age at time of vaccination and number of years since vaccination. Using a summed incidence method to control for the confounding variable introduced by mass immunization clinics held during the outbreak, vaccine efficacy was greater than 95% for children vaccinated at 12, 13, and 14 or more months of age. Vaccine efficacy for those vaccinated at 12 months of age was notably better than for those vaccinated at younger ages but not different from those vaccinated at older ages. Although recently administered vaccine appeared more efficacious than vaccine administered in the past, this difference was not significant when controlled for age at vaccination. Evaluation of the mass clinics held during the outbreak demonstrated that 59.6% of the inadequately immunized children attended the clinics, but this was not substantially different from the proportion of adequately immunized who attended (52.4%). Recommendations for measles revaccination need not include children previously vaccinated at 12 months of age or greater.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 733423

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

Authors:  M Paunio; H Peltola; M Valle; I Davidkin; M Virtanen; O P Heinonen
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  A measles outbreak at a college with a prematriculation immunization requirement.

Authors:  B S Hersh; L E Markowitz; R E Hoffman; D R Hoff; M J Doran; J C Fleishman; S R Preblud; W A Orenstein
Journal:  Am J Public Health       Date:  1991-03       Impact factor: 9.308

3.  Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.

Authors:  Nimalan Arinaminpathy; Inkyu Kevin Kim; Paul Gargiullo; Michael Haber; Ivo M Foppa; Manoj Gambhir; Joseph Bresee
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

4.  Modelling the first dose of measles vaccination: the role of maternal immunity, demographic factors, and delivery systems.

Authors:  C J E Metcalf; P Klepac; M Ferrari; R F Grais; A Djibo; B T Grenfell
Journal:  Epidemiol Infect       Date:  2010-06-07       Impact factor: 2.451

5.  The role of secondary vaccine failures in measles outbreaks.

Authors:  R G Mathias; W G Meekison; T A Arcand; M T Schechter
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

6.  An assessment of methods for routine local monitoring of vaccine efficacy, with particular reference to measles and pertussis.

Authors:  J A Clarkson; P E Fine
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

7.  Measles immunisation: results of a local programme to increase vaccine uptake.

Authors:  H Carter; I G Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

8.  Field evaluation of vaccine efficacy.

Authors:  W A Orenstein; R H Bernier; T J Dondero; A R Hinman; J S Marks; K J Bart; B Sirotkin
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

9.  Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures.

Authors:  B M Nkowane; S W Bart; W A Orenstein; M Baltier
Journal:  Am J Public Health       Date:  1987-04       Impact factor: 9.308

10.  Measles and vaccine protection.

Authors:  S R Preblud
Journal:  Br Med J       Date:  1979-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.